Phase 1 biotech developing therapies for rare autoimmune diseases.
Industry: Health Care
First Day Return: +4.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 07/02/2020 |
Offer Price | $17.00 |
Price Range $15.00 - $16.00 | |
Offer Shares (mm) | 14.8 |
Deal Size ($mm) | $251 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 07/23/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $251 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South San Francisco, CA, United States |
Founded | 2011 |
Employees at IPO | 30 |
Website www.annexonbio.com |